Searched for
DILIP B DESAI
Buy Sun Pharmaceutical Industries, target price Rs 1011.7 : ICICI DirectPrice taking support at 61.8% retracement of recent up move and 50 day EMA signaling positive bias.- Buy Sun Pharmaceutical Industries, target price Rs 1029.8 : ICICI DirectSun Pharmaceutical Industries, incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 242476.79 Crore) operating ...
- Buy Sun Pharmaceutical Industries, target price Rs 1000: Sharekhan by BNP ParibasSun Pharmaceutical Industries, incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 229664.34 Crore) operating ...
- Buy Sun Pharmaceutical Industries, target price Rs 1225: ICICI DirectHigher contribution from specialty and strong domestic franchise is likely to change the product mix towards more remunerative businesses b...
- Buy Sun Pharmaceutical Industries, price target Rs 455: Sagar DoshiThe analyst suggested a stoploss at Rs 410 .
- Morgan Stanley maintains overweight on Sun Pharma, target price Rs 530The nature of the observations will be understood once the FDA makes Form 483 public, said Morgan Stanley.
- Buy Sun Pharmaceutical Industries, target Rs 455: Kunal BothraBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 455.0 and a stoploss at Rs 425 from entry point.
- Buy Sun Pharma, price target Rs 470: Jayesh BhanushaliThe analyst suggested a stoploss at Rs 435.
- Buy Sun Pharma, target Rs 450: CK NarayanBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 450.0 and a stoploss at Rs 433 from entry point.
- Buy Sun Pharma, target price Rs 434: Jay ThakkarJay Thakkar recommended to keep stoploss at Rs 408.
- Sell Sun Pharma, target Rs 395: Shubham AggarwalSell Sun Pharmaceutical Industries Ltd. at a price target of Rs 395.0 and a stoploss at Rs 422 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 458: Kunal BothraBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 458.0 and a stoploss at Rs 425 from entry point.
- Sell Sun Pharmaceutical Industries, target Rs 380: Manas JaiswalSell Sun Pharmaceutical Industries Ltd. at a price target of Rs 380.0 and a stoploss at Rs 426 from entry point.
- Sell Sun Pharma, target Rs 390: Dr CK NarayanSell Sun Pharmaceutical Industries Ltd. at a price target of Rs 390.0 and a stoploss at Rs 420 from entry point.
- Buy Sun Pharmaceutical, target Rs 475: Sacchitanand UttekarBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 475.0 and a stoploss at Rs 443 from entry point.
- Buy Sun Pharma, target Rs 448: Dr CK NarayanBuy Sun Pharmaceutical Industries Ltd. at a price target of Rs 448.0 and a stoploss at Rs 432 from entry point.
- Buy Sun Pharmaceutical Industries, target Rs 655: Gaurav RatnaparkhiBuy Sun Pharmaceutical Industries at a price target of Rs 655 and a stop loss at Rs 588 from the entry point.
- Lakhani & Co LLP merges with Baker Tilly"We have a strong taxation practice but with this merger, our taxation practice will be one of the strongest in the co untry," said Dilip B...
- Baker Tilly DHC forms alliance to take on India's big four chartered accountant firmsAs per the new operational integration design, all new firms would now come under one umbrella and called Baker Tilly DHC.
- Baker Tilly, DHC to set up global skill centreThe alliance will herald the emergence of domestic consultancy firms in the global domain, which is dominated by the Big Four.
Load More
